Cameron D. Thomas

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C19</i> and Proton Pump Inhibitor Dosing

John J. Lima, Cameron D. Thomas, Julia M. Barbarino et al. · Clinical Pharmacology & Therapeutics · 2020 · 298 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Peripheral oxytocin administration reduces ethanol consumption in rats

Kaley MacFadyen, Rebecca Loveless, Brandon DeLucca et al. · Pharmacology Biochemistry and Behavior · 2015 · 76 citations · Full text

Pharmacy, Neuroscience, Physiology +11

Impact of the <i>CYP2C19*17</i> Allele on Outcomes in Patients Receiving Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Craig R. Lee, Cameron D. Thomas, Amber L. Beitelshees et al. · Clinical Pharmacology & Therapeutics · 2020 · 50 citations · Full text

Medicine, Cardiology, Pharmacology +17

A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management

Cameron D. Thomas, Hari K. Parvataneni, Chancellor F. Gray et al. · Genetics in Medicine · 2021 · 36 citations · Full text

Medicine, Perioperative Medicine, Surgery +8

Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment

James P. Franciosi, Edward B. Mougey, André Williams et al. · European Journal of Pediatrics · 2017 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +15